Effect on Insulin-Stimulated Release of D-Chiro-Inositol-Containing Inositolphosphoglycan Mediator during Weight Loss in Obese Women with and without Polycystic Ovary Syndrome
Background. A deficiency of D-chiro-inositol-inositolphosphoglycan mediator (DCI-IPG) may contribute to insulin resistance in polycystic ovary syndrome (PCOS). Whether the relationship between impaired DCI-IPG release and insulin resistance is specific to PCOS rather than obesity is unknown. We asse...
Saved in:
| Main Authors: | Kai I. Cheang, Sakita N. Sistrun, Kelley S. Morel, John E. Nestler |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2016-01-01
|
| Series: | International Journal of Endocrinology |
| Online Access: | http://dx.doi.org/10.1155/2016/7631804 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of Myo-Inositol-Chiro Inositol Combination on the improvement of Polycystic Ovary Syndrome Condition
by: Zuhair Assi Hussein, et al.
Published: (2024-12-01) -
Effect of myo-inositol and d-chiro-inositol on improving hormonal, metabolic and reproductive parameters in women with polycystic ovary syndrome: A review of studies
by: Aleksandra Ciuła, et al.
Published: (2025-05-01) -
Comparison of the effect of two combinations of myo-inositol and D-chiro-inositol in women with polycystic ovary syndrome undergoing ICSI: a randomized controlled trial
by: Nicolas Mendoza, et al.
Published: (2019-08-01) -
D-chiro-inositol effectively counteracts endometriosis in a mouse model
by: Martina Placidi, et al.
Published: (2025-04-01) -
Unexpected effects of treating insulin-resistant obese women with high-dose D-chiro-inositol: opening Pandora’s box
by: Sabrina Basciani, et al.
Published: (2025-04-01)